Skip to content

Architect 1E11-20

by Abbott Laboratories

Architect 1E11-20 (01E1120) is a Class II device made by Abbott Laboratories, cleared under FDA 510(k) K060709 on 15 Jun 2006 and listed in FDA GUDID since 6 Jun 2016 (UDI-DI 00380740000301), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K060709

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00380740000301 UDI-DI Date6 Jun 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK060709 Date15 Jun 2006DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K060709 decided 15 Jun 2006 Active
  • FDA GUDID UDI-DI 00380740000301 listed 6 Jun 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K060709
  2. Listed FDA GUDID 00380740000301

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Architect
Generic name
Gentamicin therapeutic drug monitoring IVD, kit, chemiluminescent immunoassay
Model / Ref / Catalog
1E11-20, 01E1120
Primary DI / UDI-DI
00380740000301
510(k) Number
FDA product code
LCD
GMDN term
Gentamicin therapeutic drug monitoring IVD, kit, chemiluminescent immunoassay
Device class
Class II
Regulation number
862.3450
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LCD (ENZYME IMMUNOASSAY, GENTAMICIN).

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)